Navigation Links
OREXIGEN Therapeutics Announces Sustained-Release Formulation of,Zonisamide Shows Improved Tolerability When Compared to Immediate,Release Formulation

orexigen.com/">http://www.orexigen.com.

Forward-Looking Statements

Orexigen cautions you that statements included in this press release that are not a description of historical facts are forward-looking statements. The inclusion of forward-looking statements should not be regarded as a representation by Orexigen that any of its plans will be achieved. For example, statements regarding the potential progress and results of clinical trials and the use of funds to support such trials may be forward looking statements. Actual results may differ materially from those set forth in this release due to the risks and uncertainties inherent in Orexigen's business, including, without limitation: Orexigen's clinical trials may not proceed in the timeframes or in the manner Orexigen expects or at all; the results of earlier clinical trials may not be predictive of future results; the scientific theories relating to the central nervous system on which Orexigen has based its development programs may not result in product candidates with sufficient efficacy or safety to obtain regulatory approval or commercial success; Orexigen and its licensors may not be able to obtain, maintain and successfully enforce adequate patent and other intellectual property protection of its product candidates; and other risks detailed in Orexigen's public filings with the Securities and Exchange Commission. You are cautioned not to place undue reliance on these forward-looking statements, which speak only as of the date hereof. All forward-looking statements are qualified in their entirety by this cautionary statement and Orexigen undertakes no obligation to revise or update this news release to reflect events or circumstances after the date hereof. This caution is made under the safe harbor provisions of Section 21E of the Private Securities Litigation Reform Act of 1995.

     CONTACTS:

     Graham Cooper         Media:                        Investors:

     Orexigen CFO 
'"/>




Page: 1 2 3 4

Related medicine technology :

1. Cell Therapeutics, Inc. Management to Discuss Todays Announcement of Interim Pixantrone Study Results
2. Halozyme Therapeutics Enhanze Technology Large Protein Molecule Therapeutic Clinical Trial Results Presented at the 34th Annual Meeting of the Controlled Release Society
3. CV Therapeutics Identifies Potential Anti-Diabetic Mechanism of Action for Ranexa
4. Fat Kills Cancer: Turning Stem Cells from Fat Tissue into Personalized, Cancer-Targeted Therapeutics
5. A 4-Week Therapy with Transition Therapeutics E1-I.N.T. Leads to Sustained Reductions in Blood Glucose Levels for 6 Months Post-treatment in Type 2 Diabetes Patients
6. Clinical Trial Suggests Bone Marrow Stem Cells Are Useful for Spinal Cord Injury; PrimeCell Therapeutics Provided Pre-Clinical Study
7. Opexa Therapeutics Reports Positive Top-line Data in Phase I/II Extension Trial with Tovaxin for Multiple Sclerosis
8. Orexigen Therapeutics to Present Data on Contrave Impact on Visceral Fat and Insulin Resistance at American Diabetes Association 67th Scientific Sessions in Chicago June 23
9. Allos Therapeutics Reports Results for Phase 3 Enrich Study of Efaproxyn in Women With Brain Metastases Originating From Breast Cancer
10. Trophos Publishes ALS Article in Journal of Pharmacology and Experimental Therapeutics
11. Novelos Therapeutics Announces Encouraging Results in Ongoing Phase 2 Ovarian Cancer Trial at Dana-Farber/Partners Cancer Care
Post Your Comments:
(Date:3/27/2015)... , March 27, 2015 Dynatronics Corporation (NASDAQ: ... has been appointed to the Company,s Board of Directors effective ... death in November 2014 of board member Joseph Barton ... to our Board of Directors represents an important step ... chairman and president of Dynatronics.  "Rich is a proven leader ...
(Date:3/27/2015)... 2015 Biopharmaceutical Industry Leads Manufacturing Sector ... out on top as the country,s manufacturing leader in ...  from ndp│analytics. According to the  analysis , the industry ... the last decade, accounting for 27 percent of average ... A Short Video on Medicare Part D - ...
(Date:3/27/2015)...   Cypher Genomics, Inc., the leading ... that, compared to a panel of experts, the ... interpretations of whether certain genetic abnormalities were likely ... fraction of the time. Cypher,s Mantis software technology ... analysis in non-invasive prenatal testing (NIPT) by enabling ...
Breaking Medicine Technology:Dynatronics Announces Appointment of Richard J. Linder to Board of Directors 2Week in Review: The Latest from PhRMA 2New Data at ACMG Shows Cypher's Software Can Automate Interpretation of Genetic Variants to Advance Non-invasive Prenatal Testing 2New Data at ACMG Shows Cypher's Software Can Automate Interpretation of Genetic Variants to Advance Non-invasive Prenatal Testing 3
(Date:3/27/2015)... Top medical tourism firm, VisitandCare.com ... the Dominican Republic to benefit from the experience of ... the medical tourism industry upside-down and becoming a choice ... services becoming the central influence. , “Trust is ... are not only attracted to low-cost surgical enhancement, but ...
(Date:3/27/2015)... 2015 On February 21, 2015, ... the Stardust Penthouse on the rooftop of the ... leading sustainable product TV and film placement producer, ... event, which featured some of the world’s top ... and services. , “We were honored to have ...
(Date:3/27/2015)... March 27, 2015 The report ... is an essential source of information on and ... in Germany. Germany’s increasingly elderly population and its ... pharmaceutical market. In 2013, the elderly accounted for ... at Compound Annual Growth Rate (CAGR) of 1.2% ...
(Date:3/27/2015)... (PRWEB) March 27, 2015 Ticket Down is ... the CenturyLink Center in Omaha, Nebraska on Friday, May ... that more concert dates will be added in Omaha as ... fan demand. , The Garth Brooks World Tour is continuing ... latest announcement that Garth Brooks and Trisha Yearwood will bring ...
(Date:3/27/2015)... and LONDON, UK (PRWEB) March 27, 2015 ... DrugDev SiteStart Melissa (Liss) Easy was named to the ... The 40 Under 40 list spotlights 40 dynamic, up-and-coming ... professional accomplishments and community involvement. Winners are honored at ... special supplement of the Philadelphia Business Journal. , Lyn ...
Breaking Medicine News(10 mins):Health News:Dominican Republic Plastic Surgery Provider Turning Medical Tourism Upside-Down 2Health News:Dominican Republic Plastic Surgery Provider Turning Medical Tourism Upside-Down 3Health News:Choices Recovery Releases 'Salute to the Oscars' EcoLuxe Lounge Compilation Video 2Health News:Germany Healthcare, Regulatory and Reimbursement Landscape Market Research Report Available at RnRMarketResearch.com 2Health News:Germany Healthcare, Regulatory and Reimbursement Landscape Market Research Report Available at RnRMarketResearch.com 3Health News:Germany Healthcare, Regulatory and Reimbursement Landscape Market Research Report Available at RnRMarketResearch.com 4Health News:Cheap Garth Brooks Tickets for CenturyLink Center in Omaha: Ticket Down Slashes Garth Brooks Concert Tickets in Omaha, NE at the CenturyLink Center 2Health News:Cheap Garth Brooks Tickets for CenturyLink Center in Omaha: Ticket Down Slashes Garth Brooks Concert Tickets in Omaha, NE at the CenturyLink Center 3Health News:DrugDev Founder Melissa Easy is 2015 Philadelphia Business Journal 40 Under 40 Honoree 2
... , ... ... ... ...
... ... ... , ... , , ...
... , ... ... , , , , ... ...
... can have strokes, and the strokes can recur, usually ... strokes often go unrecognized the first time, and the ... Pediatric neurologist Rebecca Ichord, M.D., director of the Pediatric ... today on a study of arterial ischemic stroke in ...
... ... previously unrecognized set of targets and biomarkers to battle solid tumors. , ... (Vocus) February 24, 2010 -- Cancer ... to battle solid tumors. , , , , ,The findings center on discovery of ...
... , ... ... ... ...
Cached Medicine News:Health News:Kendle Announces Fourth Quarter and Full-Year 2009 Results 2Health News:Kendle Announces Fourth Quarter and Full-Year 2009 Results 3Health News:Kendle Announces Fourth Quarter and Full-Year 2009 Results 4Health News:Kendle Announces Fourth Quarter and Full-Year 2009 Results 5Health News:Kendle Announces Fourth Quarter and Full-Year 2009 Results 6Health News:Kendle Announces Fourth Quarter and Full-Year 2009 Results 7Health News:Kendle Announces Fourth Quarter and Full-Year 2009 Results 8Health News:Kendle Announces Fourth Quarter and Full-Year 2009 Results 9Health News:Kendle Announces Fourth Quarter and Full-Year 2009 Results 10Health News:Kendle Announces Fourth Quarter and Full-Year 2009 Results 11Health News:Kendle Announces Fourth Quarter and Full-Year 2009 Results 12Health News:Kendle Announces Fourth Quarter and Full-Year 2009 Results 13Health News:Kendle Announces Fourth Quarter and Full-Year 2009 Results 14Health News:The Hub, LLC Announces Strategic Acquisition of EIM Corporation 2Health News:The Hub, LLC Announces Strategic Acquisition of EIM Corporation 3Health News:Pelosi on Repealing Antitrust Exemption: Health Insurance Companies Will Now Be Playing on the People's Field 2Health News:Pelosi on Repealing Antitrust Exemption: Health Insurance Companies Will Now Be Playing on the People's Field 3Health News:Pelosi on Repealing Antitrust Exemption: Health Insurance Companies Will Now Be Playing on the People's Field 4Health News:Pelosi on Repealing Antitrust Exemption: Health Insurance Companies Will Now Be Playing on the People's Field 5Health News:Children can have recurrent strokes 2Health News:New Cancer-Fighting Strategy Focuses On Signaling Molecules 2Health News:New Cancer-Fighting Strategy Focuses On Signaling Molecules 3Health News:China Cord Blood Corporation Acquires Stake in Shandong Cord Blood Bank 2Health News:China Cord Blood Corporation Acquires Stake in Shandong Cord Blood Bank 3Health News:China Cord Blood Corporation Acquires Stake in Shandong Cord Blood Bank 4Health News:China Cord Blood Corporation Acquires Stake in Shandong Cord Blood Bank 5Health News:China Cord Blood Corporation Acquires Stake in Shandong Cord Blood Bank 6Health News:China Cord Blood Corporation Acquires Stake in Shandong Cord Blood Bank 7
... ART Aerosol Resistant Tips offer a safe ... Tips are designed for applications such as ... In addition, ART Tips are excellent for ... forensic studies. ART Tips prevent aerosol contaminants ...
200 L, Racked, Pre-sterilized, 96 tips/rack Recommended for 20, 25, 50, 100 and 200 L pipettes. Can also be used with 300 L pipettes when pipetting 200 L or less....
... plastic-wrapped racks of 96 tips, Sterilized Diamond- ... autoclave. Sterilized Diamond Tips are irradiated by ... delivered with a certificate of sterilization, specifying ... are certified free of detectable Rnase, Dnase, ...
200 L, Racked, Pre-sterilized, 96 tips/rack, clear Recommended for 20, 25, 50, 100 and 200 L pipettes. Can also be used with 300 L pipettes when pipetting 200 L or less....
Medicine Products: